388 related articles for article (PubMed ID: 29770205)
1. Beginning at the ends: telomeres and human disease.
Savage SA
F1000Res; 2018; 7():. PubMed ID: 29770205
[TBL] [Abstract][Full Text] [Related]
2. Human telomeres and telomere biology disorders.
Savage SA
Prog Mol Biol Transl Sci; 2014; 125():41-66. PubMed ID: 24993697
[TBL] [Abstract][Full Text] [Related]
3. Dyskeratosis congenita and telomere biology disorders.
Savage SA
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
[TBL] [Abstract][Full Text] [Related]
4. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Ballew BJ; Savage SA
Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
[TBL] [Abstract][Full Text] [Related]
5. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Niewisch MR; Savage SA
Expert Rev Hematol; 2019 Dec; 12(12):1037-1052. PubMed ID: 31478401
[No Abstract] [Full Text] [Related]
6. The genetics and clinical manifestations of telomere biology disorders.
Savage SA; Bertuch AA
Genet Med; 2010 Dec; 12(12):753-64. PubMed ID: 21189492
[TBL] [Abstract][Full Text] [Related]
7. Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres.
Byrjalsen A; Brainin AE; Lund TK; Andersen MK; Jelsig AM
Hered Cancer Clin Pract; 2023 May; 21(1):7. PubMed ID: 37189188
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in dyskeratosis congenita.
Nishio N; Kojima S
Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
[TBL] [Abstract][Full Text] [Related]
9. Biallelic TERT variant leads to Hoyeraal-Hreidarsson syndrome with additional dyskeratosis congenita findings.
Çepni E; Satkın NB; Moheb LA; Rocha ME; Kayserili H
Am J Med Genet A; 2022 Apr; 188(4):1226-1232. PubMed ID: 34890115
[TBL] [Abstract][Full Text] [Related]
10. Novel
Picos-Cárdenas VJ; Beltrán-Ontiveros SA; Cruz-Ramos JA; Contreras-Gutiérrez JA; Arámbula-Meraz E; Angulo-Rojo C; Guadrón-Llanos AM; Leal-León EA; Cedano-Prieto DM; Meza-Espinoza JP
World J Clin Cases; 2022 Nov; 10(33):12440-12446. PubMed ID: 36483815
[TBL] [Abstract][Full Text] [Related]
11. The role of telomere biology in bone marrow failure and other disorders.
Savage SA; Alter BP
Mech Ageing Dev; 2008; 129(1-2):35-47. PubMed ID: 18160098
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.
Ballew BJ; Yeager M; Jacobs K; Giri N; Boland J; Burdett L; Alter BP; Savage SA
Hum Genet; 2013 Apr; 132(4):473-80. PubMed ID: 23329068
[TBL] [Abstract][Full Text] [Related]
13. Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.
Callea M; Martinelli D; Cammarata-Scalisi F; Grimaldi C; Jilani H; Grimaldi P; Willoughby CE; Morabito A
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328050
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific telomere shortening and degenerative changes in a patient with
Roake CM; Juntilla M; Agarwal-Hashmi R; Artandi S; Kuo CS
Hum Pathol (N Y); 2021 Sep; 25():. PubMed ID: 34522616
[TBL] [Abstract][Full Text] [Related]
15. Telomere length and cancer risk: finding Goldilocks.
Savage SA
Biogerontology; 2024 Apr; 25(2):265-278. PubMed ID: 38109000
[TBL] [Abstract][Full Text] [Related]
16. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
Alter BP; Rosenberg PS; Giri N; Baerlocher GM; Lansdorp PM; Savage SA
Haematologica; 2012 Mar; 97(3):353-9. PubMed ID: 22058220
[TBL] [Abstract][Full Text] [Related]
17. Treatment of telomeropathies.
Vieri M; Brümmendorf TH; Beier F
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101282. PubMed ID: 34404536
[TBL] [Abstract][Full Text] [Related]
18. Dyskeratosis Congenita Without Oral Involvement: A Rare Hereditary Disease.
Iraji F; Jamshidi K; Pourazizi M; Abtahi-Naeini B
Oman Med J; 2015 May; 30(3):212-5. PubMed ID: 26171129
[TBL] [Abstract][Full Text] [Related]
19. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
Gramatges MM; Bertuch AA
Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
[TBL] [Abstract][Full Text] [Related]
20. The wide-ranging clinical implications of the short telomere syndromes.
Barbaro PM; Ziegler DS; Reddel RR
Intern Med J; 2016 Apr; 46(4):393-403. PubMed ID: 26247919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
